Antibody to ETS-1, a transcription factor involved in cell development, differentiation, and angiogenesis – overexpression is associated with various cancers.
| Institute |
|---|
| Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) |
| Cat. #: | 162404 |
|---|---|
| Tool sub type: | Primary Antibody |
| Cancer types: | Blood cancer |
| Research Fields: | Cancer |
| Application: | ELISA, WB, IF |
| Target: | ETS-1 (DNA Binding Domain) |
| Reactivity: | Human, mouse |
| Clone: | ETS-7F2 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | Antibody to ETS-1, a transcription factor involved in cell development, differentiation, and angiogenesis – overexpression is associated with various cancers. |
|---|---|
| Additional notes: | Avoid repeat freezing and thawing cycles. Does not contain any preservative. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1, K |
| Immunogen: | synthetic peptide coupled to ovalbumine: (C)-DEVARRWGKRKNKPK corresponding to aa 368-382 of the human ETS-1 |
| Target background: | ETS-1 is a transcription factor involved in cell development, differentiation, and angiogenesis, and its overexpression is associated with various cancers. |
|---|
| Storage conditions: | -20°C (up to 3 years) |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.